Performance evaluation of an adalimumab biosimilar autoinjector and its reference device: comparative use human factors study in patients with rheumatoid arthritis and juvenile idiopathic arthritis
A Comparative Use Human Factors study was conducted to assess whether the injection success rate (SR) with biosimilar adalimumab-fkjp (Bios-ADA) autoinjector (Hulio®) is comparable to reference adalimumab (Ref-ADA) autoinjector (Humira®), accounting for design differences, including the absence of a...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2026-12-01
|
| Серія: | Drug Delivery |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/10717544.2026.2649991 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|